NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is 67076P102. A total of 31 filers reported holding NYMOX PHARMACEUTICAL CORP in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $689,000 | +163.0% | 200,148 | +1.5% | 0.14% | +187.5% |
| Q2 2015 | $262,000 | +50.6% | 197,148 | -5.0% | 0.05% | +60.0% |
| Q1 2015 | $174,000 | +109.6% | 207,526 | -0.5% | 0.03% | +130.8% |
| Q4 2014 | $83,000 | -90.5% | 208,526 | +3.9% | 0.01% | -90.4% |
| Q3 2014 | $873,000 | -9.1% | 200,701 | +3.5% | 0.14% | -11.1% |
| Q2 2014 | $960,000 | – | 193,846 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|